MoonLake Immunotherapeutics Class A Ordinary Shares(MLTX:US)
Market Cap$688.88M
Key Metrics
Price$9.55
Revenue (TTM)$0
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$257.08M
EBITDA (TTM)-$246.19M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$298.49M
Total Assets$400.37M
Net Assets$254.02M
Total Debt$100.8M
Key Metrics
Price$9.55
Revenue (TTM)$0
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$257.08M
EBITDA (TTM)-$246.19M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$298.49M
Total Assets$400.37M
Net Assets$254.02M
Total Debt$100.8M
Financials
| Name | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Sep 30, 2021 | Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| $70.02M | $65.22M | $71.43M | $60.7M | $47.49M | $49.58M | $43.11M | $30.58M | $19.82M | $15.03M | $12.98M | $13.19M | $12.93M | $16.7M | $14.77M | $17.65M | $15.94M | $6.27M | $32.68M | |
| Research and Development | $54.52M | $56.01M | $60.64M | $49.76M | $36.46M | $40.36M | $35.74M | $23.66M | $13.01M | $8.1M | $7.59M | $8.7M | $7.42M | $11.37M | $9.02M | $11.4M | $10.45M | $669.53K | $29.87M |
| Selling, General, and Administrative | $15.51M | $9.21M | $10.8M | $10.94M | $11.03M | $9.22M | $7.38M | $6.92M | $6.81M | $6.93M | $5.39M | $4.48M | $5.52M | $5.33M | $5.75M | $6.25M | $5.49M | $5.6M | $2.81M |
| Other Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income | -$70.02M | -$65.22M | -$71.43M | -$60.7M | -$47.49M | -$49.58M | -$43.11M | -$30.58M | -$19.82M | -$15.03M | -$12.98M | -$13.19M | -$12.93M | -$16.7M | -$14.77M | -$17.65M | -$15.94M | -$6.27M | -$32.68M |
| $939K | $2.45M | $855K | $4.74M | $7.08M | $3.23M | $7.09M | $5.9M | $5.92M | $7.19M | $1.39M | $842.65K | $723.59K | $239.51K | $37.59K | $245.13K | $69.51K | -$20.84K | -$3.78K | |
| Non-Operating Interest Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Non-Operating Interest Expense | $2.27M | $1.99M | $3.2M | $2.04M | $18K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Income/Expense | $3.21M | $4.44M | $4.05M | $6.78M | $7.1M | $3.23M | $7.09M | $5.9M | $5.92M | $7.19M | $1.39M | $842.65K | $723.59K | $239.51K | $37.59K | $245.13K | $69.51K | -$20.84K | -$3.78K |
Income Before Tax | -$69.09M | -$62.77M | -$70.58M | -$55.96M | -$40.41M | -$46.35M | -$36.02M | -$24.68M | -$13.91M | -$7.84M | -$11.59M | -$12.34M | -$12.21M | -$16.46M | -$14.73M | -$17.41M | -$15.87M | -$6.29M | -$32.69M |
Income Tax | $622K | $248K | $115K | $95K | $153K | $41.14K | $92.11K | $78.7K | $70.25K | $44.31K | $28.92K | $10.15K | $11.01K | $11.01K | $8.74K | $9.28K | $7.33K | $0 | $0 |
Net Income | -$69.71M | -$63.02M | -$70.69M | -$56.05M | -$40.56M | -$46.4M | -$36.11M | -$24.76M | -$13.98M | -$7.89M | -$11.62M | -$12.35M | -$12.22M | -$16.47M | -$14.74M | -$17.42M | -$15.88M | -$6.29M | -$32.69M |
Minority Interests | $0 | $591K | $965K | $831K | $615K | $791.19K | $724.09K | $491.74K | $301.87K | $450.31K | $2.19M | $2.21M | $3.21M | - | $4.63M | $5.3M | $0 | - | - |
Preferred Stock Dividends | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income to Common | -$69.71M | -$62.43M | -$69.73M | -$55.22M | -$39.94M | -$45.6M | -$35.39M | -$24.27M | -$13.67M | -$7.44M | -$9.43M | -$10.14M | -$9M | -$16.47M | -$10.11M | -$12.12M | -$15.88M | -$6.29M | -$32.69M |
Shares Outstanding (Basic) | 71.27M | - | 63.37M | 63.28M | 63.23M | 63.07M | 62.9M | 62.87M | 62.64M | - | 53.52M | 43.72M | 39.06M | 38.84M | 36.93M | 35.2M | 36.93M | 36.93M | 36.93M |
Shares Outstanding (Diluted) | 71.27M | - | 63.37M | 63.28M | 63.23M | 63.07M | 62.9M | 62.87M | 62.64M | - | 53.52M | 43.72M | 39.06M | 38.84M | 36.93M | 35.2M | 36.93M | 36.93M | 36.93M |
EPS (Basic) | -$0.98 | - | -$1.10 | -$0.87 | -$0.63 | -$0.72 | -$0.56 | -$0.39 | -$0.22 | - | -$0.18 | -$0.23 | -$0.23 | -$0.31 | -$0.27 | -$0.34 | -$0.43 | -$0.17 | -$0.89 |
EPS (Diluted) | -$0.98 | - | -$1.10 | -$0.87 | -$0.63 | -$0.72 | -$0.56 | -$0.39 | -$0.22 | - | -$0.18 | -$0.23 | -$0.23 | -$0.31 | -$0.27 | -$0.34 | -$0.43 | -$0.17 | -$0.89 |
EBIT | -$66.82M | -$60.78M | -$67.38M | -$53.92M | -$40.39M | -$49.58M | -$43.11M | -$30.58M | -$19.82M | -$15.03M | -$12.98M | -$13.19M | -$12.93M | -$16.7M | -$14.77M | -$17.65M | -$15.94M | -$6.27M | -$32.68M |
EBITDA | -$65.97M | -$60.03M | -$66.64M | -$53.56M | -$40.01M | -$48.28M | -$43.09M | -$30.54M | -$19.8M | -$15.03M | -$12.42M | -$13.29M | -$12.93M | -$16.69M | -$14.77M | -$17.65M | -$15.94M | -$6.26M | -$32.68M |